MetaCap

Eikon Therapeutics (EIKN) News

NASDAQ: EIKNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

4.74-0.02 (-0.42%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

EIKN news summary

We found 8 recent headlines mentioning Eikon Therapeutics (EIKN): 1 in the past week and 5 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, EIKN is down 0.42% at $4.74. The most recent story, "Eikon Therapeutics Announces Clearance to Proceed with First-in-Human Phase 1/2 Study for Novel Androgen Receptor Antagonist EIK1006 in Advanced Metastatic Prostate Cancer", was published by GlobeNewswire on Nov 17, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Eikon Therapeutics headlines

Stocks mentioned alongside EIKN

Compare EIKN